Peter Tomassen

Peter Tomassen

Auto-generated profile, based on publicly available information

Peter Tomassen

Department of Otorhinolaryngology and Head and Neck Surgery, Ghent University Hospital, Belgium

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
PTPeter Tomassen
Peter Tomassen
GVGriet Vandeplas
Griet Vandeplas
TZThibaut Van Zele
Thibaut Van Zele
LCLars-Olaf Cardell
Lars-Olaf Cardell
JAJulia Arebro
Julia Arebro
CBClaus Bachert
Claus Bachert
Current phenotyping of chronic rhinosinusitis (CRS) into chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis without nasal polyps (CRSsNP) might not adequately reflect the pathophysiologic diversity within patients with CRS. We sought to identify inflammatory endotypes of CRS. Therefore we aimed to cluster patients with CRS based solely on immune markers in a phenotype-free approach. Secondarily, we aimed to match clusters to phenotypes. In this multicenter case-control study patients with CRS and control subjects underwent surgery, and tissue was analyzed for IL-5, IFN-γ, IL-17A, TNF-α, IL-22, IL-1β, IL-6, IL-8, eosinophilic cationic protein, myeloperoxidase, TGF-β1, IgE, Staphylococcus aureus enterotoxin-specific IgE, and albumin. We used partition-based clustering. Clustering of 173 cases resulted in 10 clusters, of which 4 clusters with low or undetectable IL-5, eosinophilic cationic protein, IgE, and albumin concentrations, and 6 clusters with high concentrations of those markers. The group of IL-5-negative clusters, 3 clusters clinically resembled a predominant chronic rhinosinusitis without nasal polyps (CRSsNP) phenotype without increased asthma prevalence, and 1 cluster had a TH17 profile and had mixed CRSsNP/CRSwNP. The IL-5-positive clusters were divided into a group with moderate IL-5 concentrations, a mixed CRSsNP/CRSwNP and increased asthma phenotype, and a group with high IL-5 levels, an almost exclusive nasal polyp phenotype with strongly increased asthma prevalence. In the latter group, 2 clusters demonstrated the highest concentrations of IgE and asthma prevalence, with all samples expressing Staphylococcus aureus enterotoxin-specific IgE. Distinct CRS clusters with diverse inflammatory mechanisms largely correlated with phenotypes and further differentiated them and provided a more accurate description of the inflammatory mechanisms involved than phenotype information only.

24 May 2011 in Allergy
Verified
Journal Article
Closed access
PDF file
DHD. Hastan
D. Hastan
WFW. J. Fokkens
W. J. Fokkens
CBC. Bachert
C. Bachert
RNR. B. Newson
R. B. Newson
JBJ. Bislimovska
J. Bislimovska
PBP. Burney
P. Burney

4 November 2011 in Allergy
Verified
Journal Article
Closed access
PDF file
DJD. Jarvis
D. Jarvis
RNR. Newson
R. Newson
JLJ. Lotvall
J. Lotvall
DHD. Hastan
D. Hastan
PTP. Tomassen
P. Tomassen
PBP. Burney
P. Burney

1 October 2011 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
KCKoen Van Crombruggen
Koen Van Crombruggen
NZNan Zhang
Nan Zhang
PGPhilippe Gevaert
Philippe Gevaert
PTPeter Tomassen
Peter Tomassen
CBClaus Bachert
Claus Bachert

1 February 2019 in Rhinology journal
Verified
Journal Article
Closed access
AKA. Khan
A. Khan
GVG. Vandeplas
G. Vandeplas
THT.M.T. Huynh
T.M.T. Huynh
VJV.N. Joish
V.N. Joish
LML. Mannent
L. Mannent
CBC. Bachert
C. Bachert
Chronic rhinosinusitis (CRS) is a common yet under-recognised chronic inflammatory disease of the nose and paranasal sinuses that is classified according to the presence (CRSwNP) or absence (CRSsNP) of nasal polyps. This paper reports the methodology and descriptive results of the Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort. We established a large CRS cohort within the GALEN consortium (European FP6 research initiative) to identify inflammatory endotypes, the natural disease course, and its impact on health-related quality of life (HRQoL). Detailed information on the impact of CRS on HRQoL, comorbidity incidence, objective disease measures, and medical and surgical treatments were collected. This multicentre cross-sectional case-control study recruited 935 adults (869 eligible for analysis: 237 CRSsNP; 445 CRSwNP; 187 controls [reference group]). Comorbidities such as asthma, allergy, eczema, food allergy, urticaria, and chronic obstructive pulmonary disease were significantly more frequent in CRS patients. Nasal corticosteroids, antibiotics, and oral corticosteroids were the most common treatments. Significantly more CRSwNP patients reported previous sinonasal surgery. This study provides detailed information that facilitates studying CRS and its main phenotypes. However, patient distribution of this study does not necessarily reflect disease distribution in the general population.

22 July 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
MBMargot Baudelet
Margot Baudelet
LSLeen Van Den Steen
Leen Van Den Steen
PTPeter Tomassen
Peter Tomassen
KBKatrien Bonte
Katrien Bonte
PDPhilippe Deron
Philippe Deron
FDFréderic Duprez
Fréderic Duprez